STAT+: With two new insurance partnerships, EQRx takes its first steps toward lowering drug prices. But how big are those steps?
EQRx — the buzzy biotech company with a lofty mission of making far less expensive…
Category: payers
STAT+: Buying the data: Health care lobbyists fund their own policy analyses, clouding Washington debates
WASHINGTON — Sen. Chuck Grassley’s voice boomed through the Senate hearing room — it sounded…